High prevalence of TROP2 expression identifies EBV-positive gastric cancer as a candidate for TROP2-directed antibody-drug conjugates.
Overview & Synopsis
Open access biomedical research article published in Langenbecks Arch Surg.
Indexed from repository: PubMed Central
(
pmc.ncbi.nlm.nih.gov)
Keyboard Shortcuts:
← / → for pages • + / - for zoom • 0 to fit width
Powered by Mozilla PDF.js v3.11
Document Information
| Document Title | High prevalence of TROP2 expression identifies EBV-positive gastric cancer as a candidate for TROP2-directed antibody-drug conjugates. |
|---|---|
| Author / Organization | Wagner T, Weiten R, Lyu SI, Pamuk A, Heidenreich A, Bruns CJ, Quaas A, Alakus H, Schleussner N |
| Subject & Discipline | Langenbecks Arch Surg |
| Categories | Medicine & Health |
| Publication Year | 2026 |
| License / Rights | Open Access / Creative Commons |
| Resource Verification | Listed PDF (Verification Pending) |
| Original Host Website |
PubMed Central
(pmc.ncbi.nlm.nih.gov)
|
| File Format | application/pdf (Portable Document Format) |
| Language | EN |
| Catalog ID | DOC-151452 |
| Original Source Link | Visit Source Page on pmc.ncbi.nlm.nih.gov » |